Healthcare / Medical Care FacilitiesSwiss
$12.90
-0.10 (-0.77%)
FCF base 3Y
n/d
n/d CAGR · yield n/d
FCF base 5Y
n/d
n/d base · n/d expected
Precio de entrada
n/d
MOS 34% · confianza 16%
FCF escenarios
weak_data · normalized FCF $-18.8M · quality 37.0/100
Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.
SA Score
10/100
F
Piotroski
5/9
balance/quality
Valuation
50/100
+0.0% upside
5Y CAGR
+0.0%
50/100
Data QA
16/100
SEC 0%
Sin guardar todavía.
Market Cap
$1.1B
P/E
N/A
•EV/EBITDA
23.9x
↑ROE
-3.9%
↓Gross Margin
80.1%
↑Debt/Equity
1.86
↑TradingView lightweight chart
Absolute Values (Left Axis)
Ratios / Percentages (Right Axis)
Financial statement dashboard
2022–2025 · 3 años de histórico normalizado
Revenue CAGR
+3.2%
FCF CAGR
-50.5%
FCF margin
0.4%
FCF / Net income
-0.24x
Latest source
Provider fallback
Margin decomposition
Último año: revenue $1.20B · net income $-20.1M · FCF $4.9M
Gross margin
Operating margin
Net margin
FCF margin
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $1.20B | $1.20B | $1.01B | $952.9M | $1.09B |
| Net Income | $-20.1M | $-20.1M | $-2.9M | $-39.3M | $58.8M |
| EBITDA | $84.0M | $84.0M | $97.0M | $53.5M | $155.8M |
| EPS | — | — | -0.03 | -0.47 | 0.69 |
| Gross Margin | 80.1% | 80.1% | 78.2% | 78.5% | 79.3% |
| Operating Margin | -1.3% | -1.3% | -2.4% | -2.3% | 0.6% |
| Net Margin | -1.7% | -1.7% | -0.3% | -4.1% | 5.4% |
| Balance Sheet | |||||
| Debt/Equity | 1.86 | 1.86 | 2.02 | 2.04 | 2.07 |
| Current Ratio | 0.67 | 0.67 | — | — | — |
| Cash Flow | |||||
| Free Cash Flow | $4.9M | $4.9M | $-18.8M | $-66.1M | $40.3M |
| Returns | |||||
| ROE | -3.9% | -3.9% | -0.5% | -8.0% | 12.5% |
| Valuation | |||||
| P/E | — | — | — | — | 26.88 |
| EV/EBITDA | 23.92 | 23.92 | 23.06 | 42.64 | 15.92 |
| P/B | 2.14 | 2.14 | 2.26 | 2.76 | 3.38 |
| Growth & Yield | |||||
| Revenue Growth | 18.4% | 18.4% | 6.0% | -12.4% | — |
| EPS Growth | — | — | 93.6% | -168.1% | — |
Revenue, Net Income & Free Cash Flow ($B)
Margins (%)
Returns (%)
Leverage & Liquidity
Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.
Total return
-6.2%
Start / end P/E
n/dx → n/dx
EPS bridge
-0.03 → n/d
Residual
-6.2%
EPS/multiple decomposition requires positive EPS at both endpoints; residual absorbs price move not explained by dividends.
Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.